BM Cimicifuga Racemosa 30 [hp_C]/1000mg

Cimicifuga Racemosa · GLOBULE · BM Private Limited

No Recall History

Plain English

BM Cimicifuga Racemosa is a globule containing cimicifuga racemosa at 30 [hp_C]/1000mg, taken oral. Manufactured by BM Private Limited.

Key Facts

No Recall History

FDA FAERS database · These are reported events, not confirmed side effects

hypotension10 reports

bradycardia9 reports

cardiac arrest9 reports

drug interaction9 reports

nausea9 reports

overdose9 reports

pulseless electrical activity9 reports

diverticulitis5 reports

fall5 reports

fatigue5 reports

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & dosage: Referred to enclosed self help guide or as advised by a homoeopathic physician.

Indications & dosage: Referred to enclosed self help guide or as advised by a homoeopathic physician.

Precautions/storage: Keep away from children and store at cool and dry place.

Care & contra-indications: This is a homoeopathic remedy, no contra-indications are established.

BM Cimicifuga Racemosa contains Cimicifuga Racemosa. It is a globule taken oral. Consult your doctor for specific uses.

BM Cimicifuga Racemosa is not classified as a controlled substance by the DEA.

The generic name for BM Cimicifuga Racemosa is Cimicifuga Racemosa. There are 11 other brand versions of Cimicifuga Racemosa.

The NDC (National Drug Code) for BM Cimicifuga Racemosa 30 [hp_C]/1000mg is 85816-5041, listed by BM Private Limited.

Product NDC

85816-5041

Package NDC

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)